Comvita Limited
Comvita Limited (CVNZF) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cvnzf · pe ratio · data through Jun 30, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Comvita Limited (CVNZF) measures how much investors pay for each dollar of the company's trailing earnings. CVNZF's current PE ratio of N/A is calculated by dividing its stock price of $0.42 by its TTM earnings per share of -$1.33.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-06-30
PE Ratio History
2004 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 16 fiscal years · Front-end computedMinQ1 · 25%15.8x
MedianQ3 · 75%89.8x
Max
At N/A, CVNZF's current P/E is lower than in 0% of its annual fiscal year readings over the past 16 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Packaged Foods · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Comvita LimitedYou CVNZF | $30M | N/A | — | -$1.33 |
 Burcon NutraScience Corporation BRCNF | $18M | N/A | — | -$1.06 |
 Bubs Australia Limited BUBSF | $69M | 22.03x | -69.2% | $0.01 |
 Crimson Wine Group, Ltd. CWGL | $92M | 164.61x | +130.1% | $0.03 |
 Global Bio-chem Technology Group Company Limited GBCMY | $74M | 5.26x | -92.6% | $0.72 |
 LeanLife Health Inc. LNLHF | $3M | N/A | — | -$0.02 |
 Natural Beauty Bio-Technology Limited NBBTF | $122M | 94.27x | +31.8% | $0.01 |
Industry Average 4 peers with valid PE | — | 71.54x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-06-30Latest FY2025 | — | $-1.49 | — | |
2024-06-30 FY2024 | — | $-1.10 | — | |
2023-06-30 FY2023 | 17.18x | $0.16 | +2.4% | |
2022-06-30 FY2022 | 16.77x | $0.18 | -32.1% | |
2021-06-30 FY2021 | 24.69x | $0.14 | — | |
2020-06-30 FY2020 | — | $-0.19 | — | |
2019-06-30 FY2019 | — | $-0.56 | — | |
2018-06-30 FY2018 | 50.73x | $0.17 | +94.8% | |
2017-06-30 FY2017 | 26.03x | $0.22 | -14.2% | |
2016-06-30 FY2016 | 30.35x | $0.37 | +141.0% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Comvita Limited (CVNZF) measures how much investors pay for each dollar of the company's trailing earnings. CVNZF's current PE ratio of N/A is calculated by dividing its stock price of $0.42 by its TTM earnings per share of -$1.33.
Frequently asked questions
CVNZF pe ratio · 6 questionsCVNZF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.42 and TTM EPS of -$1.33. Data sourced from Financial Modeling Prep via CVNZF's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Comvita Limited SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09